Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2013 1
2014 1
2015 5
2016 3
2017 1
2018 5
2019 6
2020 4
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Among authors: cavaleri m. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
Schönborn L, Seck SE, Thiele T, Kaderali L, Hoffmann T, Hlinka A, Lindhoff-Last E, Völker U, Selleng K, Buoninfante A, Cavaleri M, Greinacher A. Schönborn L, et al. Among authors: cavaleri m. J Thromb Haemost. 2023 Sep;21(9):2519-2527. doi: 10.1016/j.jtha.2023.06.027. Epub 2023 Jun 30. J Thromb Haemost. 2023. PMID: 37394120
Animal models for COVID-19.
Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Muñoz-Fontela C, et al. Among authors: cavaleri m. Nature. 2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23. Nature. 2020. PMID: 32967005 Free PMC article. Review.
Bacteriophage therapy: a regulatory perspective.
Pelfrene E, Willebrand E, Cavaleiro Sanches A, Sebris Z, Cavaleri M. Pelfrene E, et al. Among authors: cavaleri m. J Antimicrob Chemother. 2016 Aug;71(8):2071-4. doi: 10.1093/jac/dkw083. Epub 2016 Apr 10. J Antimicrob Chemother. 2016. PMID: 27068400
Shaping EU medicines regulation in the post COVID-19 era.
Cavaleri M, Sweeney F, Gonzalez-Quevedo R, Carr M. Cavaleri M, et al. Lancet Reg Health Eur. 2021 Oct;9:100192. doi: 10.1016/j.lanepe.2021.100192. Epub 2021 Oct 7. Lancet Reg Health Eur. 2021. PMID: 34661185 Free PMC article. Review.
Attention for sex in COVID-19 trials: a review of regulatory dossiers.
de Vries ST, Starokozhko V, Schellens IMM, Wijnans L, Enzmann H, Cavaleri M, Mol PGM. de Vries ST, et al. Among authors: cavaleri m. BMJ Glob Health. 2022 Mar;7(3):e008173. doi: 10.1136/bmjgh-2021-008173. BMJ Glob Health. 2022. PMID: 35304352 Free PMC article. Review.
Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?
Eichler HG, Cavaleri M, Enzmann H, Scotti F, Sepodes B, Sweeney F, Vamvakas S, Rasi G. Eichler HG, et al. Among authors: cavaleri m. Clin Pharmacol Ther. 2020 Oct;108(4):730-733. doi: 10.1002/cpt.1891. Epub 2020 Jun 12. Clin Pharmacol Ther. 2020. PMID: 32407539 Free PMC article. Review.
A global regulatory science agenda for vaccines.
Elmgren L, Li X, Wilson C, Ball R, Wang J, Cichutek K, Pfleiderer M, Kato A, Cavaleri M, Southern J, Jivapaisarnpong T, Minor P, Griffiths E, Sohn Y, Wood D. Elmgren L, et al. Among authors: cavaleri m. Vaccine. 2013 Apr 18;31 Suppl 2:B163-75. doi: 10.1016/j.vaccine.2012.10.117. Vaccine. 2013. PMID: 23598478 Free article. Review.
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. Moore KA, et al. Vaccine. 2021 Oct 29;39(45):6573-6584. doi: 10.1016/j.vaccine.2021.08.010. Epub 2021 Sep 30. Vaccine. 2021. PMID: 34602302 Free article. Review.
40 results